MBIO

Mustang Bio (MBIO)

Mustang Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MBIO

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/03	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/12/07	07:00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:MBIO	Mustang Bio Inc
2024/12/03	06:45	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MBIO	Mustang Bio Inc
2024/11/29	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MBIO	Mustang Bio Inc
2024/11/23	06:45	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:MBIO	Mustang Bio Inc
2024/11/16	06:50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/11/12	22:30	GlobeNewswire Inc.	Mustang Bio Receives Positive Listing Determination from Nasdaq	NASDAQ:MBIO	Mustang Bio Inc
2024/11/09	06:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MBIO	Mustang Bio Inc
2024/11/07	22:30	GlobeNewswire Inc.	Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma	NASDAQ:MBIO	Mustang Bio Inc
2024/11/07	07:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/10/30	05:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MBIO	Mustang Bio Inc
2024/10/26	05:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/10/25	03:10	GlobeNewswire Inc.	Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds	NASDAQ:MBIO	Mustang Bio Inc
2024/09/14	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/08/17	06:08	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:MBIO	Mustang Bio Inc
2024/08/14	05:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MBIO	Mustang Bio Inc
2024/07/30	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MBIO	Mustang Bio Inc
2024/07/20	06:26	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:MBIO	Mustang Bio Inc
2024/07/11	05:41	Edgar (US Regulatory)	Form DEF 14C - Other definitive information statements	NASDAQ:MBIO	Mustang Bio Inc
2024/06/22	05:01	GlobeNewswire Inc.	Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:MBIO	Mustang Bio Inc
2024/06/20	21:00	GlobeNewswire Inc.	Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:MBIO	Mustang Bio Inc
2024/06/20	21:00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:MBIO	Mustang Bio Inc
2024/06/17	21:30	GlobeNewswire Inc.	Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy	NASDAQ:MBIO	Mustang Bio Inc
2024/06/13	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MBIO	Mustang Bio Inc
2024/06/07	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/06/05	09:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MBIO	Mustang Bio Inc
2024/06/05	09:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MBIO	Mustang Bio Inc
2024/06/01	06:09	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:MBIO	Mustang Bio Inc
2024/05/22	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/05/13	19:01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MBIO	Mustang Bio Inc